By Carles Celma|2023-04-19T12:14:52+02:00October 12th, 2022|Events 2023, Ticker|Comments Off on AFI Symposium: Rimini, IT | 07-09 Jun 2023 | Booth #94
Elemental Impurities: New regulations for human and veterinary pharmaceuticals and cosmetic products
Elemental impurities in pharmaceutical but also cosmetic products are increasingly receiving the attention of the authorities. New limits are being defined constantly and it is essential to always be up to date with the latest regulations. Gemma Solsona, Head of Department for Elemental Impurities, informs about the most important recent regulatory developments: “Currently, several changes (...) Read more
Quantifying Active Enzymes – A bioanalytical challenge
Lisa Hentschel, Master of Molecular Biosciences, started her career at Prolytic eight years ago as a technician in the ELISA team. Since 2017, she now leads the Biology Department and is a recognized expert in large molecule bioanalysis, ADA determination and enzyme activity measurement. Together with Dr Busch, COO at Eleva, she shares her (...) Read more
Analytical Development & Validation: The Entry Gate Of Your Project
Rosa Latorre, PhD in Analytical Chemistry and Director of the Analytical Development and Validation Department at Kymos, started her career in big pharmaceutical multinationals such as Merck, Grifols and Ipsen before joining Kymos - which in 2009 was a much smaller CRO than today - to provide analytical services for those global players she had (...) Read more
Percutaneous Absorption: Like a Second Skin
An important function of the skin is to protect the body from the environment, and it is normally a very effective barrier against external substances. In some cases, however, penetration of active substances (API) into the skin is desired to provide a therapeutic effect. Hence, manufacturers of pharmaceutical topical products must test how well (...) Read more
Your Stability Studies in Safe Hands
In recent years Kymos has experienced a surge in demand from drug manufacturers in need of a reliable outsourcing partner for their stability programmes. Kymos responded by making a major investment to build new climatic chambers in their sites in Spain and Italy to reach today’s 100m³ of storage capacity for all conditions corresponding (...) Read more
Upscaling in instruments leads to downscaling in limits of detection
Upscaling in instruments leads to downscaling in limits of detection Kymos celebrates the recent purchase of two new API-6500 plus instruments, the most sensitive in the market, to boost our bioanalytical capabilities for small molecules in our Frankfurt und Barcelona sites. Together with our third API-6500 coupled to an Agilent UHPLC, two high-sensitivity APIs (...) Read more
